Man Group PLC disclosed a reduction in its long position in Senior Plc shares and related cash-settled derivatives as of June 9, 2026. The total interest held after the dealings is approximately 1.77% of Senior Plc's relevant securities. The sales included ordinary shares and equity swaps at a price of £2.8706 per share. This move signals a slight decrease in Man Group's exposure to Senior Plc, which may impact market perceptions of the stock's future performance.
OpenYield secured over $6 million in Series A funding led by LeveL Markets, which will integrate OpenYield's automated bond trading platform into its equities venue. This partnership aims to bring equity-like transparency, speed, and firm pricing to ...
Joe Lonsdale, co-founder of Palantir, believes SpaceX's current valuation overlooks its long-term potential, especially as a key player in AI infrastructure. He argues that trillions of dollars will be invested in AI over the next five years, positio...
Kimco Realty OP, LLC announced a proposed private offering of $500 million in exchangeable senior notes due 2031, with an option to increase by $75 million. The notes will be senior, unsecured, and exchangeable for Kimco common stock under certain co...
Technology and semiconductor stocks experienced a sharp sell-off ahead of SpaceX's $75 billion IPO, causing a debate among Wall Street experts. Tom Lee from Fundstrat described the dip as a "healthy" market consolidation linked to institutional cash ...
Kuva Labs has initiated a tender offer to buy all outstanding shares of Lisata Therapeutics at $4.00 per share in cash, with an additional contingent value right (CVR) offering up to $3.00 per share if certain clinical milestones are met. The Lisata ...
